ANI Pharmaceuticals Launches Generic Cymbalta

MT newswire2026/10/19 11:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

07:32 AM EDT, 10/19/2026 (MT Newswires) -- ANI Pharmaceuticals (ANIP) launched generic duloxetine delayed-release capsules in 20 mg, 30 mg and 60 mg, offering an alternative to Eli Lilly's (LLY) Cymbalta, the drugmaker said Monday. The launch expands access to a widely used treatment in a market with limited competition, ANI said. US annual sales of duloxetine delayed-release capsules, a treatment for major depressive disorder in adults, reached about $247 million, based on IQVIA data for the 12 months ended August, ANI said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The Housing Market Index, jointly released by the National Association of Home Builders (NAHB) and Wells Fargo, fell by 3 points this month to 29, the lowest level since June 2012 and below the market expectation of 31. The sales sub-index dropped to 33, also a 14-year low; the index for expected sales over the next six months declined to its weakest level since November 2022; the index measuring potential buyer traffic fell to its lowest point since the onset of the COVID-19 pandemic.

华尔街见闻•2026/10/19 15:16